Testing effectiveness (Phase 2)Study completedNCT00589875
What this trial is testing
Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma
Who this might be right for
Malignant GliomaGlioblastoma MultiformeAnaplastic Astrocytoma+1 more
Candel Therapeutics, Inc. 52